JW (Cayman) Therapeutics Co. Ltd carries a market capitalization of 84.28M, placing it among publicly traded companies globally.
| Market Cap | 84.28M |
| Enterprise Value | N/A |
JW (Cayman) Therapeutics Co. Ltd's stock has declined approximately -55.28853% over the past 52 weeks. The 50-day moving average sits at 0.20, while the 200-day moving average is 0.26.
| Beta (5Y) | N/A |
| 52-Week Price Change | -55.28853% |
| 50-Day Moving Average | 0.20 |
| 200-Day Moving Average | 0.26 |
| Average Volume (20 Days) | N/A |
Already premium? Sign in